Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 174,940 | 147,683 | 160,850 | 161,296 | 179,921 |
| Cost of Goods | 72,668 | 53,557 | 59,247 | 59,572 | 60,384 |
| Gross Profit | 102,272 | 94,126 | 101,603 | 101,724 | 119,537 |
| Operating Expenses | 45,728 | 36,485 | 39,288 | 33,733 | 44,539 |
| Operating Income | 57,212 | 58,198 | 62,562 | 68,563 | 75,382 |
| Other Income | 11,131 | 12,352 | 9,894 | 18,123 | -1,257 |
| Pre-tax Income | 68,343 | 70,550 | 72,456 | 86,686 | 74,125 |
| Income Tax | 13,920 | 2,874 | 16,246 | 20,445 | 15,649 |
| Net Income Continuous | 54,423 | 67,676 | 56,210 | 66,241 | 58,476 |
| Minority Interests | 225 | -6 | 32 | 58 | 42 |
| Net Income | $54,198 | $67,682 | $56,178 | $66,183 | $58,434 |
| EPS Basic Total Ops | 1.41 | 1.76 | 1.46 | 1.72 | 1.52 |
| EPS Basic Continuous Ops | 1.42 | 1.76 | 1.46 | 1.72 | 1.52 |
| EPS Diluted Total Ops | 1.41 | 1.76 | 1.46 | 1.72 | 1.52 |
| EPS Diluted Continuous Ops | 1.42 | 1.76 | 1.46 | 1.72 | 1.52 |
| EBITDA(a) | $62,494 | $63,645 | $68,145 | $73,634 | $80,241 |